{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T08:08:56Z","timestamp":1784880536945,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T00:00:00Z","timestamp":1544140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T00:00:00Z","timestamp":1544140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2019,3,15]]},"DOI":"10.1007\/s11060-018-03074-y","type":"journal-article","created":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T15:15:22Z","timestamp":1544195722000},"page":"139-148","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Etiology and prognosis of acute respiratory failure in patients with primary malignant brain tumors admitted to the intensive care unit"],"prefix":"10.1007","volume":"142","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3552-5053","authenticated-orcid":false,"given":"Maxens","family":"Decav\u00e8le","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Rivals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mence","family":"Marois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Cantier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9a","family":"Lemasle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Prodanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khe","family":"Hoang-Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Idbaih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Similowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Demoule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,7]]},"reference":[{"key":"3074_CR1","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/01.md.0000145370.63676.fb","volume":"83","author":"E Azoulay","year":"2004","unstructured":"Azoulay E, Thi\u00e9ry G, Chevret S et al (2004) The prognosis of acute respiratory failure in critically ill cancer patients. Medicine (Baltimore) 83:360\u2013370","journal-title":"Medicine (Baltimore)"},{"key":"3074_CR2","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1200\/JCO.2012.47.2365","volume":"31","author":"E Azoulay","year":"2013","unstructured":"Azoulay E, Mokart D, P\u00e8ne F, Schlemmer B, Chevret S, Lemiale V (2013) Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium--a groupe de recherche respiratoire en r\u00e9animation onco-h\u00e9matologique study. J Clin Oncol 31:2810\u20132818","journal-title":"J Clin Oncol"},{"key":"3074_CR3","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1007\/s00134-014-3354-0","volume":"40","author":"E Azoulay","year":"2014","unstructured":"Azoulay E, Lemiale V, Mokart D et al (2014) Acute respiratory distress syndrome in patients with malignancies. Intensive Care Med 40:1106\u20131114","journal-title":"Intensive Care Med"},{"key":"3074_CR4","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1007\/s00134-006-0129-2","volume":"32","author":"E Azoulay","year":"2006","unstructured":"Azoulay E, Schlemmer B (2006) Diagnostic strategy in cancer patients with acute respiratory failure. Intensive Care Med 32:808\u2013822","journal-title":"Intensive Care Med"},{"key":"3074_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11060-015-2015-7","volume":"127","author":"E Tabouret","year":"2016","unstructured":"Tabouret E, Boucard C, Devillier R, Barrie M, Boussen S, Autran D, Chinot O, Bruder N (2016) Neuro-oncological patients admitted in intensive-care unit: predictive factors and functional outcome. J Neurooncol 127:111\u2013117","journal-title":"J Neurooncol"},{"key":"3074_CR6","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1007\/s00415-017-8624-7","volume":"264","author":"M Decav\u00e8le","year":"2017","unstructured":"Decav\u00e8le M, Weiss N, Rivals I et al (2017) Prognosis of patients with primary malignant brain tumors admitted to the intensive care unit: a two-decade experience. J Neurol 264:2303\u20132312","journal-title":"J Neurol"},{"key":"3074_CR7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1023\/A:1024217527650","volume":"63","author":"AK Mahindra","year":"2003","unstructured":"Mahindra AK, Grossman SA (2003) Pneumocystis carinii pneumonia in HIV negative patients with primary brain tumors. J Neurooncol 63:263\u2013270","journal-title":"J Neurooncol"},{"key":"3074_CR8","first-page":"203","volume":"18","author":"M Wesling","year":"2013","unstructured":"Wesling M, Brady S, Jensen M, Nickell M, Statkus D, Escobar N (2013) Dysphagia outcomes in patients with brain tumors undergoing inpatient rehabilitation. Dysphagia 18:203\u2013210","journal-title":"Dysphagia"},{"key":"3074_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11060-015-2010-z","volume":"127","author":"WH Lee","year":"2016","unstructured":"Lee WH, Oh BM, Seo HG et al (2016) One-year outcome of postoperative swallowing impairment in pediatric patients with posterior fossa brain tumor. J Neurooncol 127:73\u201381","journal-title":"J Neurooncol"},{"key":"3074_CR10","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.3109\/10428194.2012.753446","volume":"54","author":"D Mokart","year":"2013","unstructured":"Mokart D, Lambert J, Schnell D et al (2013) Delayed intensive care unit admission is associated with increased mortality in patients with cancer with acute respiratory failure. Leuk Lymphoma 54:1724\u20131729","journal-title":"Leuk Lymphoma"},{"key":"3074_CR11","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803\u2013820","journal-title":"Acta Neuropathol"},{"key":"3074_CR12","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/S0090-3019(00)00213-5","volume":"53","author":"J Vaquero","year":"2000","unstructured":"Vaquero J, Mart\u00ednez R, Manrique M (2000) Stereotactic biopsy for brain tumors: is it always necessary? Surg Neurol 53:432\u2013437","journal-title":"Surg Neurol"},{"key":"3074_CR13","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649\u2013655","journal-title":"Am J Clin Oncol"},{"key":"3074_CR14","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","volume":"47","author":"M Charlson","year":"1994","unstructured":"Charlson M, Szatrowski TP, Peterson J, Gold J (1994) Validation of a combined comorbidity index. J Clin Epidemiol 47:1245\u20131251","journal-title":"J Clin Epidemiol"},{"key":"3074_CR15","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1001\/jama.1993.03510240069035","volume":"270","author":"JR Le Gall","year":"1993","unstructured":"Le Gall JR, Lemeshow S, Saulnier FA (1993) New simplified acute physiology score (SAPS II) based on a European\/North American multicenter study. JAMA 270:2957\u20132963","journal-title":"JAMA"},{"key":"3074_CR16","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/BF01709751","volume":"22","author":"JL Vincent","year":"1996","unstructured":"Vincent JL, Moreno R, Takala J et al (1996) The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction\/failure. On behalf of the working group on sepsis-related problems of the European Society of intensive care medicine. Intensive Care Med 22:707\u2013710","journal-title":"Intensive Care Med"},{"key":"3074_CR17","doi-asserted-by":"publisher","first-page":"S578","DOI":"10.1097\/01.CCM.0000143020.27340.FF","volume":"32","author":"JC Gea-Banacloche","year":"2004","unstructured":"Gea-Banacloche JC, Opal SM, Jorgensen J, Carcillo JA, Sepkowitz KA, Cordonnier C (2004) Sepsis associated with immunosuppressive medications: an evidence-based review. Crit Care Med 32:S578\u2013S590","journal-title":"Crit Care Med"},{"key":"3074_CR18","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/S0140-6736(09)61416-1","volume":"374","author":"AJ Ferreri","year":"2009","unstructured":"Ferreri AJ, Reni M, Foppoli M et al (2009) High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial. Lancet 374:1512\u20131520","journal-title":"Lancet"},{"key":"3074_CR19","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1097\/MD.0b013e3181f2caef","volume":"89","author":"O Wolach","year":"2010","unstructured":"Wolach O, Bairey O, Lahav M (2010) Late-onset neutropenia after rituximab treatment: case series and comprehensive review of the literature. Medicine (Baltimore) 2010 89:308\u2013318","journal-title":"Medicine (Baltimore)"},{"key":"3074_CR20","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/BF00165480","volume":"27","author":"D Schiff","year":"1996","unstructured":"Schiff D (1996) Pneumocystis pneumonia in brain tumor patients: risk factors and clinical features. J Neurooncol 27:235\u2013240","journal-title":"J Neurooncol"},{"key":"3074_CR21","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1001\/archneur.1991.00530160074017","volume":"48","author":"JW Henson","year":"1991","unstructured":"Henson JW, Jalaj JK, Walker RW, Stover DE, Fels AO (1991) Pneumocystis carinii pneumonia in patients with primary brain tumors. Arch Neurol 48:406\u2013409","journal-title":"Arch Neurol"},{"key":"3074_CR22","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4065\/71.1.5","volume":"71","author":"SH Yale","year":"1996","unstructured":"Yale SH, Limper AH (1996) Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. Mayo Clin Proc 71:5\u201313","journal-title":"Mayo Clin Proc"},{"key":"3074_CR23","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.ijrobp.2004.12.085","volume":"62","author":"MA Hughes","year":"2005","unstructured":"Hughes MA, Parisi M, Grossman S, Kleinberg L (2005) Primary brain tumors treated with steroids and radiotherapy: low CD4 counts and risk of infection. Int J Radiat Oncol Biol Phys 62:1423\u20131426","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3074_CR24","doi-asserted-by":"crossref","unstructured":"Sengupta S, Marrinan J, Frishman C, Sampath P (2012) Impact of temozolomide on immune response during malignant glioma chemotherapy. Clin Dev Immunol 2012:831090","DOI":"10.1155\/2012\/831090"},{"key":"3074_CR25","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s11060-017-2668-5","volume":"136","author":"AJ Lin","year":"2018","unstructured":"Lin AJ, Campian JL, Hui C et al (2018) Impact of concurrent versus adjuvant chemotherapy on the severity and duration of lymphopenia in glioma patients treated with radiation therapy. J Neurooncol 136:403\u2013411","journal-title":"J Neurooncol"},{"key":"3074_CR26","doi-asserted-by":"publisher","first-page":"116","DOI":"10.7326\/0003-4819-112-9-716_1","volume":"112","author":"RL Leff","year":"1990","unstructured":"Leff RL, Mckenzie R (1990) Rheumatoid arthritis, methotrexate therapy and Pneumocystis pneumonia. Ann Intern Med 112:116","journal-title":"Ann Intern Med"},{"key":"3074_CR27","doi-asserted-by":"publisher","first-page":"633","DOI":"10.5535\/arm.2013.37.5.633","volume":"37","author":"DH Park","year":"2013","unstructured":"Park DH, Chun MH, Lee SJ, Song YB (2013) Comparison of swallowing functions between brain tumor and stroke patients. Ann Rehabil Med 37:633\u2013641","journal-title":"Ann Rehabil Med"},{"key":"3074_CR28","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.wneu.2013.01.035","volume":"82","author":"R Wadhwa","year":"2014","unstructured":"Wadhwa R, Toms J, Chittiboina P et al (2014) Dysphagia following posterior fossa surgery in adults. World Neurosurg 82:822\u2013827","journal-title":"World Neurosurg"},{"key":"3074_CR29","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S0889-8553(03)00024-4","volume":"32","author":"CD Lind","year":"2003","unstructured":"Lind CD (2003) Dysphagia evaluation and treatment. Gastroenterol Clin N Am 32:553\u2013575","journal-title":"Gastroenterol Clin N Am"},{"key":"3074_CR30","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1093\/neuonc\/4.4.278","volume":"4","author":"M Wrensch","year":"2002","unstructured":"Wrensch M, Minn Y, Chew T et al (2002) Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol 4:278\u2013299","journal-title":"Neuro Oncol"},{"key":"3074_CR31","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.thromres.2014.12.013","volume":"135","author":"TM Petterson","year":"2015","unstructured":"Petterson TM, Marks RS, Ashrani AA et al (2015) Risk of site-specific cancer in incident venous thromboembolism: a population-based study. Thromb Res 135:472\u2013478","journal-title":"Thromb Res"},{"key":"3074_CR32","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3171\/jns.2007.106.4.601","volume":"106","author":"TJ Semrad","year":"2007","unstructured":"Semrad TJ, O\u2019Donnell R, Wun T et al (2007) Epidemiology of venous thromboembolism in 9489 patients with malignant glioma. J Neurosurg 106:601\u2013608","journal-title":"J Neurosurg"},{"key":"3074_CR33","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s11060-010-0462-8","volume":"104","author":"MT Sartori","year":"2011","unstructured":"Sartori MT, Della Puppa A, Ballin A et al (2011) Prothrombotic state in glioblastoma multiforme: an evaluation of the procoagulant activity of circulating microparticles. J Neurooncol 104:225\u2013231","journal-title":"J Neurooncol"},{"key":"3074_CR34","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1001\/jama.2008.656","volume":"300","author":"SR Nalluri","year":"2008","unstructured":"Nalluri SR, Chu D, Keresztes R et al (2008) Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis. JAMA 300:2277\u20132285","journal-title":"JAMA"},{"key":"3074_CR35","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.4065\/82.9.1052","volume":"82","author":"H Green","year":"2007","unstructured":"Green H, Paul M, Vidal L, Leibovici L (2007) Prophylaxis of pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials. Mayo Clin Proc 82:1052\u20131059","journal-title":"Mayo Clin Proc"},{"key":"3074_CR36","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/annonc\/mdu050","volume":"25","author":"R Stupp","year":"2014","unstructured":"Stupp R, Brada M, van den Bent MJ, Tonn JC, Pentheroudakis G, ESMO Guidelines Working Group.(2014) High-grade glioma ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 25:93\u2013101","journal-title":"Ann Oncol"},{"key":"3074_CR37","doi-asserted-by":"publisher","first-page":"e322","DOI":"10.1016\/S1470-2045(15)00076-5","volume":"16","author":"K Hoang-Xuan","year":"2015","unstructured":"Hoang-Xuan K, Bessell E, Bromberg J et al (2015) European association for Neuro-Oncology task force on primary CNS lymphoma. Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European association for Neuro-Oncology. Lancet Oncol 16:e322\u2013e332","journal-title":"Lancet Oncol"},{"key":"3074_CR38","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1200\/JCO.2014.59.7351","volume":"33","author":"GH Lyman","year":"2015","unstructured":"Lyman GH, Bohlke K, Khorana AA et al (2015) Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline Update 2014. J Clin Oncol 33:654\u2013656","journal-title":"J Clin Oncol"},{"key":"3074_CR39","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/S0140-6736(05)66691-3","volume":"365","author":"MS Dennis","year":"2005","unstructured":"Dennis MS, Lewis SC, Warlow C (2005) FOOD Trial Collaboration: Effect of timing and method of enteral tube feeding for dysphagic stroke patients (FOOD): a multicentre randomised controlled trial. Lancet 365:764\u2013772","journal-title":"Lancet"},{"key":"3074_CR40","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1212\/WNL.0b013e3181fef115","volume":"75","author":"MS Troche","year":"2010","unstructured":"Troche MS, Okun MS, Rosenbek JC et al (2010) Aspiration and swallowing in Parkinson disease and rehabilitation with EMST: a randomized trial. Neurology 75:1912\u20131919","journal-title":"Neurology"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-018-03074-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-018-03074-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-018-03074-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T01:36:24Z","timestamp":1744076184000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-018-03074-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,7]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,3,15]]}},"alternative-id":["3074"],"URL":"https:\/\/doi.org\/10.1007\/s11060-018-03074-y","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,7]]},"assertion":[{"value":"8 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Alexandre Demoule has signed research contracts with Covidien, Maquet, Philips and Ait Liquide Sant\u00e9; he has also received personal fees from Covidien, Maquet and MSD. Ahmed Idbaih reports research funding from La Fondation ARC pour la recherche sur le Cancer, Carthera, Beta-Innov, and Intselchimos; travel funding from Hoffmann-La Roche; and personal fees from Novartis, La Lettre du Canc\u00e9rologue, BMS, and Cipla unrelated to the submitted work. Nicolas Weiss has signed research contracts with Eumedica, BMS, MedDay pharmaceuticals; he has also received personal fees from Norgine and Alpha-Wasserman. Thomas Similowski has received grant research from Coviden, Philips, Pierre Fabre M\u00e9dicaments, Air Liquide Medical Systems; he has also received personal fees from Takeda, Teva Pharma, Lungpacer Inc, Almirall France, Pierre Fabre M\u00e9dicaments, Novartis, Mundipharma, Invacare, Astra Zeneca, Boehringer Ingelheim and GlaxoSmithKline. H\u00e9l\u00e8ne Prodanovic, Kh\u00ea Hoang-Xuan, Cl\u00e9mence Marois, Isabelle Rivals, Marie Cantier, L\u00e9a Lemasle and Maxens Decav\u00e8le all declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"According to the French Public Health Code (L.1121-1 paragraph 1 and R1121-2,), informed consent is unnecessary for anonymous extraction and analysis of data from patients\u2019 medical charts. The study was approved by the Institutional Review Board of the French Intensive Care Society.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals and informed consent."}}]}}